Premature atherosclerotic peripheral artery disease: An underrecognized and undertreated disorder with a rising global prevalence

Kullo, 2016, CLINICAL PRACTICE. Peripheral Artery Disease, N Engl J Med, 374, 861, 10.1056/NEJMcp1507631 Ouriel, 2001, Peripheral arterial disease, Lancet, 358, 1257, 10.1016/S0140-6736(01)06351-6 Members, 2017, 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: executive Summary: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, Circulation, 135, e686 Fowkes, 2008, Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis, JAMA, 300, 197, 10.1001/jama.300.2.197 McDermott, 2001, Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment, JAMA, 286, 1599, 10.1001/jama.286.13.1599 McDermott, 1999, Leg symptoms, the ankle-brachial index, and walking ability in patients with peripheral arterial disease, J Gen Intern Med, 14, 173, 10.1046/j.1525-1497.1999.00309.x McDermott, 2007, Baseline Functional Performance Predicts the Rate of Mobility Loss in Persons With Peripheral Arterial Disease, J. Am. Coll. Cardiol., 50, 974, 10.1016/j.jacc.2007.05.030 Allison, 2007, Ethnic-specific prevalence of peripheral arterial disease in the United States, Am J Prev Med, 32, 328, 10.1016/j.amepre.2006.12.010 Fowkes, 2013, Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis, Lancet, 382, 1329, 10.1016/S0140-6736(13)61249-0 Song, 2019, Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis, Lancet Glob Health, 7, e1020, 10.1016/S2214-109X(19)30255-4 Benjamin, 2019, Heart Disease and Stroke Statistics-2019 Update: a Report From the American Heart Association, Circulation, 139, e56, 10.1161/CIR.0000000000000659 Barretto, 2003, Early-onset peripheral arterial occlusive disease: clinical features and determinants of disease severity and location, Vasc Med, 8, 95, 10.1191/1358863x03vm475oa Maillet, 2017, Peripheral Atheromatous Arterial Disease in the Young: risk Factors, Clinical Features, and Prognosis From the COPART Cohort, Angiology, 68, 893, 10.1177/0003319717699501 Levy, 1994, Lower extremity ischemia in adults younger than forty years of age: a community-wide survey of premature atherosclerotic arterial disease, J. Vasc. Surg., 19, 873, 10.1016/S0741-5214(94)70013-3 Valentine, 1999, The progressive nature of peripheral arterial disease in young adults: a prospective analysis of white men referred to a vascular surgery service, J. Vasc. Surg., 30, 436, 10.1016/S0741-5214(99)70070-4 Rana, 2013, Mortality in patients with premature lower extremity atherosclerosis, J. Vasc. Surg., 57, 28, 10.1016/j.jvs.2012.07.041 Aboyans, 2012, Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association, Circulation, 126, 2890, 10.1161/CIR.0b013e318276fbcb Selvin, 2004, Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000, Circulation, 110, 738, 10.1161/01.CIR.0000137913.26087.F0 Lopez-Melgar, 2017, Subclinical Atherosclerosis Burden by 3D Ultrasound in Mid-Life: the PESA Study, J Am Coll Cardiol, 70, 301, 10.1016/j.jacc.2017.05.033 Joosten, 2012, Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men, JAMA, 308, 1660, 10.1001/jama.2012.13415 Tsimikas, 2017, A Test in Context: lipoprotein(a): diagnosis, Prognosis, Controversies, and Emerging Therapies, J Am Coll Cardiol, 69, 692, 10.1016/j.jacc.2016.11.042 Bérard, 2013, Novel Risk Factors for Premature Peripheral Arterial Occlusive Disease in Non-Diabetic Patients: a Case-Control Study, PLoS ONE, 8, e37882, 10.1371/journal.pone.0037882 Valentine, 2004, Family history is a major determinant of subclinical peripheral arterial disease in young adults, J. Vasc. Surg., 39, 351, 10.1016/j.jvs.2003.07.011 Kullo, 2015, The genetic basis of peripheral arterial disease: current knowledge, challenges, and future directions, Circ Res, 116, 1551, 10.1161/CIRCRESAHA.116.303518 Hutter, 2004, Familial Hypercholesterolemia, Peripheral Arterial Disease, and Stroke: a HuGE Minireview, Am. J. Epidemiol., 160, 430, 10.1093/aje/kwh238 Boers, 1985, Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease, N Engl J Med, 313, 709, 10.1056/NEJM198509193131201 Helgadottir, 2008, The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm, Nat Genet, 40, 217, 10.1038/ng.72 Thorgeirsson, 2008, A variant associated with nicotine dependence, lung cancer and peripheral arterial disease, Nature, 452, 638, 10.1038/nature06846 Levy, 1994, Lower extremity ischemia in adults younger than forty years of age: a community-wide survey of premature atherosclerotic arterial disease, J. Vasc. Surg., 19, 873, 10.1016/S0741-5214(94)70013-3 Torrealba, 2019, Hypercoagulability predicts worse outcomes in young patients undergoing lower extremity revascularization, J. Vasc. Surg., 70, 175, 10.1016/j.jvs.2018.09.062 Lane, 2006, Risk factors for premature peripheral vascular disease: results for the National Health and Nutritional Survey, 1999-2002, J. Vasc. Surg., 44, 319, 10.1016/j.jvs.2006.04.015 Erdozain, 2014, Peripheral arterial disease in systemic lupus erythematosus: prevalence and risk factors, J Rheumatol, 41, 310, 10.3899/jrheum.130817 Liang, 2006, Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations, Arthritis Rheum, 54, 642, 10.1002/art.21628 Beckman, 2018, Association of Human Immunodeficiency Virus Infection and Risk of Peripheral Artery Disease, Circulation, 138, 255, 10.1161/CIRCULATIONAHA.117.032647 Unnikrishnan, 2017, Type 2 Diabetes: demystifying the Global Epidemic, Diabetes, 66, 1432, 10.2337/db16-0766 Hoffman, 2019, Cigarette consumption estimates for 71 countries from 1970 to 2015: systematic collection of comparable data to facilitate quasi-experimental evaluations of national and global tobacco control interventions, BMJ, 365, l2231, 10.1136/bmj.l2231 Story, 2017, Contemporary Characteristics and Outcomes of Young Patients (Under 50 Years) Undergoing Open Carotid Artery Surgery, Ann Vasc Surg, 44, 375, 10.1016/j.avsg.2017.01.017 Miech, 2019, Trends in Adolescent Vaping, 2017-2019, N Engl J Med, 381, 1490, 10.1056/NEJMc1910739 Lee, 2019, Modeling Cardiovascular Risks of E-Cigarettes With Human-Induced Pluripotent Stem Cell-Derived Endothelial Cells, J Am Coll Cardiol, 73, 2722, 10.1016/j.jacc.2019.03.476 Franzen, 2018, E-cigarettes and cigarettes worsen peripheral and central hemodynamics as well as arterial stiffness: a randomized, double-blinded pilot study, Vasc Med, 23, 419, 10.1177/1358863X18779694 Caporale, 2019, Acute Effects of Electronic Cigarette Aerosol Inhalation on Vascular Function Detected at Quantitative MRI, Radiology, 293, 97, 10.1148/radiol.2019190562 Denegri, 2016, Lower limb ischemia due to long-term abuse of cocaine, J Cardiovasc Med (Hagerstown), 17, e176, 10.2459/JCM.0000000000000083 Bachi, 2017, Vascular disease in cocaine addiction, Atherosclerosis, 262, 154, 10.1016/j.atherosclerosis.2017.03.019 Tan, 2019, Peripheral vascular manifestation in patients receiving an amphetamine analog: a case series, Vasc Med, 24, 50, 10.1177/1358863X18790101 Conte, 2015, Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication, J. Vasc. Surg., 61, 2S, 10.1016/j.jvs.2014.12.009 Khan, 2006, Does the clinical examination predict lower extremity peripheral arterial disease, JAMA, 295, 536, 10.1001/jama.295.5.536 Bonaca, 2018, Peripheral Artery Diseases Beckman, 2019, Peripheral Artery Disease: clinical Evaluation Bailey, 2014, Clinical assessment of patients with peripheral arterial disease, Semin Intervent Radiol, 31, 292, 10.1055/s-0034-1393964 Rutherford, 1997, Recommended standards for reports dealing with lower extremity ischemia: revised version, J. Vasc. Surg., 26, 517, 10.1016/S0741-5214(97)70045-4 Fontaine, 1954, [Surgical treatment of peripheral circulation disorders], Helv Chir Acta, 21, 499 Grundy, 2019, 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: executive Summary: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, J Am Coll Cardiol, 73, 3168, 10.1016/j.jacc.2018.11.002 Willigendael, 2005, Smoking and the patency of lower extremity bypass grafts: a meta-analysis, J. Vasc. Surg., 42, 67, 10.1016/j.jvs.2005.03.024 Hiatt, 2017, Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease, N Engl J Med, 376, 32, 10.1056/NEJMoa1611688 Bonaca, 2016, Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease, J Am Coll Cardiol, 67, 2719, 10.1016/j.jacc.2016.03.524 Anand, 2018, Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial, Lancet, 391, 219, 10.1016/S0140-6736(17)32409-1 Bonaca, 2013, Vorapaxar in patients with peripheral artery disease: results from TRA2{degrees}P-TIMI 50, Circulation, 127, 1522, 10.1161/CIRCULATIONAHA.112.000679 Bonaca, 2018, Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial, Lancet Diabetes Endocrinol, 6, 934, 10.1016/S2213-8587(18)30290-0 Bonaca, 2018, Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk), Circulation, 137, 338, 10.1161/CIRCULATIONAHA.117.032235 Neal, 2017, Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes, N Engl J Med, 377, 644, 10.1056/NEJMoa1611925 Whelton, 2018, Hypertension, 71, 1269, 10.1161/HYP.0000000000000066 Ostergren, 2004, Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease, Eur Heart J, 25, 17, 10.1016/j.ehj.2003.10.033 Hamburg, 2011, Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits, Circulation, 123, 87, 10.1161/CIRCULATIONAHA.109.881888 Treat-Jacobson, 2019, Implementation of Supervised Exercise Therapy for Patients With Symptomatic Peripheral Artery Disease: a Science Advisory From the American Heart Association, Circulation, 140, e700, 10.1161/CIR.0000000000000727 Klingelhoefer, 2016, Predictive factors for better bypass patency and limb salvage after prosthetic above-knee bypass reconstruction, J. Vasc. Surg., 64, 380, 10.1016/j.jvs.2016.02.059